ARCHIVES

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

This article is from The Cancer Letter archive.

Vol. 31 No. 43 | November 23, 2005

Download PDF Visit The Full Archive

Related Articles

Obey Accuses Industry Of Blocking Control Of Carcinogens

November 10, 1978

In Brief: Einhorn Named Karnofsky Lecturer; Consensus Conferences On Colon, Breast Cancer Planned

February 2, 1990

St. John’s Wort Not Indicated For Patients On Irinotecan

May 31, 2002

Enter The Cancer Letter’s 35th Anniversary Story Contest

July 31, 2009

NCAB Committee, SORDS Agree On New Training Grants In Surgical Oncology

January 11, 1985

NCI to Support Research and Development Of Image Guided Therapy for Prostate Cancer

July 16, 1999